 |
市場調査レポート
商品コード
1373842
薬物スクリーニングの世界市場 (2023-2030年)：タイプ (アルコール・大麻)・エンドユーザ (薬物検査・職場) 別の規模・シェア・成長分析・予測Global Drug Screening Market Size, Share, Growth Analysis, By Type(Alcohol, Cannabis), By End-User(Drug testing laboratories and Workplaces) - Industry Forecast 2023-2030 |
||||||
| 薬物スクリーニングの世界市場 (2023-2030年)：タイプ (アルコール・大麻)・エンドユーザ (薬物検査・職場) 別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月30日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の薬物スクリーニングの市場規模は、2021年の53億米ドル、2022年の62億2,000万米ドルから、予測期間中は17.3％のCAGRで推移し、2030年には261億5,000万米ドルの規模に成長すると予測されています。
世界の薬物スクリーニングの市場は、ヘルスケア産業の中で急成長している分野であり、個人における薬物またはその代謝物の存在の検出に焦点を当てています。薬物スクリーニングは、職場、病院、スポーツ組織、法執行機関など、さまざまな場面で重要な役割を果たしており、違法物質の使用や処方薬の誤用の可能性がある個人の特定に役立っています。この市場はいくつかの要因によって牽引されています。まず第一に、世界中で薬物乱用と中毒の蔓延が増加しているため、効果的なスクリーニング方法に対する大きな需要が生じています。世界中の政府や組織は、薬物乱用の社会的・経済的影響をますます認識するようになっており、薬物検査を義務付ける規制と政策の強化につながっています。世界の薬物スクリーニング市場のもう1つの主な促進要因は、職場の安全性が重視され、企業による薬物フリー政策の実施が増加していることです。雇用主は、従業員の生産性を確保し、事故を減らし、法的責任を最小限に抑えるために、薬物のない職場環境を維持することの重要性を認識するようになってきています。
当レポートでは、世界の薬物スクリーニングの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の薬物スクリーニング市場：タイプ別
- 市場概要
- アルコール
- 大麻
- コカイン
- オピオイド
- アンフェタミン・メタンフェタミン
- LSD
- 世界の薬物スクリーニング市場：エンドユーザー別
- 市場概要
- 薬物検査ラボ
- 職場
- 世界の薬物スクリーニング市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- LabCorp
- Quest Diagnostic
- Abbott
- Thermo Fisher Scientific, Inc.
- Alfa Scientific Designs, Inc.
- OraSure Technologies, Inc.
- Siemens
- F. Hoffmann-La Roche Ltd
- MPD Inc.
- Shimadzu Corporation
- Lifeloc Technologies, Inc
- Dragerwerk AG & Co. KGaA
- Premier Biotech, Inc.
- Omega Laboratories, Inc. (US)
- Psychemedics Corporation (US)
- Clinical Reference Laboratory Inc., (US)
- American Bio Medica Corporation (US)
- Company Overview
- Sciteck, Inc.
- Synens SAS
Global Drug Screening Market size was valued at USD 5.3 billion in 2021 and is poised to grow from USD 6.22 billion in 2022 to USD 26.15 billion by 2030, growing at a CAGR of 17.3% during the forecast period (2023-2030).
The global drug screening market is a rapidly growing sector within the healthcare industry that focuses on detecting the presence of drugs or their metabolites in individuals. Drug screening plays a crucial role in various settings, including workplaces, hospitals, sports organizations, and law enforcement agencies, as it helps identify individuals who may be using illicit substances or misusing prescription drugs. The market is driven by several factors. First and foremost, the rising prevalence of drug abuse and addiction worldwide has created a significant demand for effective screening methods. Governments and organizations across the globe are increasingly recognizing the social and economic impact of drug abuse, leading to stricter regulations and policies that require drug testing. Another key driver for the global drug screening market is the increasing emphasis on workplace safety and the implementation of drug-free policies by companies. Employers are increasingly realizing the importance of maintaining a drug-free work environment to ensure employee productivity, reduce accidents, and minimize legal liabilities. In conclusion, the global market is experiencing significant growth driven by factors such as the increasing prevalence of drug abuse, technological advancements, workplace safety initiatives, and sports industry requirements. As drug screening becomes more crucial in various sectors, the market is expected to continue expanding in the coming years, with ongoing advancements in testing methods and regulations playing a pivotal role in shaping its future.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Drug Screening Market Segmental Analysis
Global Drug Screening Market is segmented by type, end-user, and region. Based on type, the market can be segmented into Alcohol, Cannabis, Cocaine, Opioids, Amphetamine and Methamphetamine, and LSD. Based on end-user, the market is segmented into drug test laboratories and workplaces. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Drug Screening Market Dynamics
Drivers of the Global Drug Screening Market
Growing Drugs Consumption
As drug screening products and services are increasingly used on the road, it is anticipated that the expanding use of illicit drugs will also hasten the market's overall expansion. Additionally, teen drug use will support market expansion. Additionally, the screening is simple to put into practise, providing flexible and successful workplace drug testing, which is also anticipated to support market expansion. One important element that is anticipated to temper the market's expansion is the rise in government spending to combat drug trafficking. Future drug screening market growth will be further accelerated by the rise in traffic accidents brought on by drugged driving and prescription medication abuse.
Restraints in the Global Drug Screening Market
Prohibition of Drug Testing
Drug testing is viewed as a violation of employee privacy in some settings, particularly the workplace, which is predicted to slow market expansion. The drug screening business is expected to be challenged by restrictions on drug use in some locations and problems with breathalyser accuracy.
Market Trends of Global Drug Screening Key
The global drug screening market is witnessing several key market trends that are shaping its growth and trajectory. Firstly, there is a growing adoption of advanced technologies in drug screening. This includes the development of more sensitive and accurate testing methods, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays, which enhance the detection capabilities of drug screening procedures. Another significant trend is the increasing focus on oral fluid drug testing. Saliva-based drug screening offers non-invasive sample collection and provides a convenient alternative to urine and blood tests. It has a shorter detection window but offers real-time drug use detection and is particularly valuable in post-accident and roadside testing scenarios. Overall, the key market trends in the drug screening industry revolve around advanced technologies, rapid on-site testing, oral fluid testing, expanded drug panels, and the integration of AI and ML. These trends reflect the industry's continuous efforts to enhance accuracy, convenience, and efficiency in drug screening processes.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Drug Screening Market by Type
- Market Overview
- Alcohol
- Cannabis
- Cocaine
- Opioids
- Amphetamine and Methamphetamine
- and LSD
- Global Drug Screening Market by End-User
- Market Overview
- Drug testing laboratories and Workplaces
- Global Drug Screening Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alfa Scientific Designs, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OraSure Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MPD Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lifeloc Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Premier Biotech, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Clinical Reference Laboratory Inc., (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- American Bio Medica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synens SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
